IA
LJPC

IFP Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

IFP Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-150
Closed -$4K – 4214
2018
Q2 		$4K Hold
150
– – ﹤0.01% 3440
2018
Q1 		$5K Hold
150
– – ﹤0.01% 3231
2017
Q4 		$5K Hold
150
– – ﹤0.01% 3280
2017
Q3 		$5K Hold
150
– – ﹤0.01% 3467
2017
Q2 		$4K Hold
150
– – ﹤0.01% 3581
2017
Q1 		$4K Hold
150
– – ﹤0.01% 3486
2016
Q4 		$3K Hold
150
– – ﹤0.01% 3606
2016
Q3 		$4K Hold
150
– – ﹤0.01% 3415
2016
Q2 		$2K Buy
+150
New +$2.69K ﹤0.01% 3570
2016
Q1 		– Sell
-150
Closed -$4K – 4583
2015
Q4 		$4K Buy
+150
New +$4.09K ﹤0.01% 3147

Other funds holding LJPC

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

IFP Advisors's LJPC Position: Q3 2018 in Review

IFP Advisors sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2018, closing a stake of 150 shares — an estimated $4K sold.

IFP Advisors first reported a position in LJPC in Q4 2015 and held it in 10 quarters. The position peaked at $5K in Q1 2018. 78 funds tracked by Wall St. Rank hold LJPC as of Q3 2018.

  • IFP Advisors reported no remaining La Jolla Pharmaceutical Company position as of Q3 2018 after selling out during the quarter.
  • IFP Advisors sold 150 La Jolla Pharmaceutical Company shares in Q3 2018, an estimated $4K.
  • IFP Advisors first reported a position in La Jolla Pharmaceutical Company in Q4 2015 and held it in 10 quarters.
  • IFP Advisors's La Jolla Pharmaceutical Company position peaked at $5K in Q1 2018.
  • 78 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2018.

Based on IFP Advisors's 13F filing for Q3 2018, filed 25 Oct 2018.